Akero Therapeutics | S-3ASR:“知名成熟發行人”證券註冊聲明
Akero Therapeutics | 10-Q:季度報表
Akero Therapeutics | 8-K:Akero Therapeutics公佈2024年第一季度財務業績並提供業務最新情況
Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | 4:持股變動聲明-高管 Gangloff Scott A.
Akero Therapeutics | 3:首次持股聲明-高管 Gangloff Scott A.
Akero Therapeutics | ARS:年度報告
Akero Therapeutics | DEF 14A:股東委託書決議
Akero Therapeutics | PRE 14A:並購重組委托聲明
Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | 144:擬議出售證券
Akero Therapeutics | 8-K:重大事件
Akero Therapeutics | 4:持股變動聲明-高管 Yale Catriona
Akero Therapeutics | 4:持股變動聲明-高管 White William Richard
Akero Therapeutics | 4:持股變動聲明-高管 Cheng Andrew
Akero Therapeutics | 4:持股變動聲明-高管 Rolph Timothy
Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | SC 13G:超過5%持股股東披露文件-General Atlantic, L.P.(7.7%),General Atlantic Partners 100, L.P.(7.7%)等
Akero Therapeutics | 4:持股變動聲明-高管 Cheng Andrew
Akero Therapeutics | 4:持股變動聲明-高管 Yale Catriona
暫無數據